Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds
- PMID: 275252
Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds
Abstract
Hexamethylenebisacetamide is a potent inducer of erythroid differentiation in murine erythroleukemia cells. A series of chemical compounds structurally related to hexamethylenebisacetamide were tested for inducing activity including polymethylene chains terminally substituted with various combinations of carboxylate, amino, amide, or sulfoxide groups. Effective "dimerization" of dimethyl sulfoxide through a linear polymethylene chain increases its inducing activity by a magnitude similar to that observed when N-methylacetamide is effectively dimerized in such a manner. It was found that all potent inducing agents possess both a hydrophilic and hydrophobic portion of the molecule, as well as a planar portion. All are Lewis bases, possessing a free electron pair available for hydrogen bonding. The polymethylene chain joining functional groups must be flexible and must be 5 to 6 carbon atoms in length to achieve maximal activity. Introduction of triple or double (cis or trans) bonds into the polymethylene chain does not alter activity.
Similar articles
-
A new group of potent inducers of differentiation in murine erythroleukemia cells.Proc Natl Acad Sci U S A. 1976 Mar;73(3):862-6. doi: 10.1073/pnas.73.3.862. Proc Natl Acad Sci U S A. 1976. PMID: 1062798 Free PMC article.
-
Differentiation of erythroleukemia cells in vitro: properties of chemical inducers.Cell Differ. 1975 Jun;4(3):179-85. doi: 10.1016/0045-6039(75)90039-1. Cell Differ. 1975. PMID: 1056810
-
Cryoprotective agents as inducers of erythroleukemic cell differentiation in vitro.Blood. 1976 Mar;47(3):363-8. Blood. 1976. PMID: 1062223
-
The phenomenon of differentiation in murine erythroleukemic cells.Harvey Lect. 1978;72:253-81. Harvey Lect. 1978. PMID: 86529 Review. No abstract available.
-
In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation.Carcinog Compr Surv. 1982;7:359-77. Carcinog Compr Surv. 1982. PMID: 7039831 Review. No abstract available.
Cited by
-
Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions.Cancer Chemother Pharmacol. 1988;22(1):65-8. doi: 10.1007/BF00254184. Cancer Chemother Pharmacol. 1988. PMID: 3396146
-
Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.Proc Natl Acad Sci U S A. 1989 Aug;86(16):6358-62. doi: 10.1073/pnas.86.16.6358. Proc Natl Acad Sci U S A. 1989. PMID: 2762329 Free PMC article.
-
Potent cytodifferentiating agents related to hexamethylenebisacetamide.Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5542-6. doi: 10.1073/pnas.88.13.5542. Proc Natl Acad Sci U S A. 1991. PMID: 2062836 Free PMC article.
-
Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.Environ Health Perspect. 1989 Mar;80:181-8. doi: 10.1289/ehp.8980181. Environ Health Perspect. 1989. PMID: 2647479 Free PMC article. Review.
-
Differentiation of Friend erythroleukemia cells induced by benzodiazepines.Proc Natl Acad Sci U S A. 1984 Jun;81(12):3770-2. doi: 10.1073/pnas.81.12.3770. Proc Natl Acad Sci U S A. 1984. PMID: 6587392 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources